Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06618144 · ClinicalTrials.gov registry record · NA
Conversational Artificial Intelligence (AI) to Improve PeRiconception Care Access
A NA study of Early Pregnancy Loss and Early Pregnancy, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT06618144 is a NA study of Early Pregnancy Loss and Early Pregnancy that has completed, run by University of Pennsylvania. The registered enrollment target is 350 participants, above the 107-participant average among 3 other Early Pregnancy Loss trials with a reported enrollment target (227% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06618144, a NA study of Early Pregnancy Loss and Early Pregnancy, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project, Conversational Artificial Intelligence (AI) to Improve PeRiconception Care Access (CIRCA), is to engage patients in care early in pregnancy (before prenatal care starts) and safely triage concerns to PEACE to reduce unnecessary emergency department visits.
Conditions Studied
Interventions
- OTHER Texting platform
Study Locations (1)
Pennsylvania
- University of Pennsylvania Health System - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2024-08-20 |
| Est. Completion | 2025-09-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06618144
The ClinicalTrials.gov registry entry for NCT06618144 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 107-participant average among 3 other Early Pregnancy Loss trials with a reported enrollment target (227% higher). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Early Pregnancy Loss appearing as the primary indexed condition, and to 1 intervention - of which Texting platform is the first listed.
NCT06618144 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06618144 about?
NCT06618144 is a clinical study titled "Conversational Artificial Intelligence (AI) to Improve PeRiconception Care Access". The goal of this project, Conversational Artificial Intelligence (AI) to Improve PeRiconception Care Access (CIRCA), is to engage patients in care early in pregnancy (before prenatal care starts) and safely triage concerns to PEACE to reduce unnecessary emergency department visits.
What is the current status of trial NCT06618144?
This trial is currently completed. It is a NA study. The enrollment target is 350 participants. The study started on 2024-08-20. Estimated completion is 2025-09-21.
What conditions does trial NCT06618144 study?
This clinical trial studies the following conditions: Early Pregnancy Loss, Early Pregnancy.
What interventions are being tested in trial NCT06618144?
The interventions under investigation include: Texting platform (OTHER).
Who is sponsoring clinical trial NCT06618144?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06618144 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Early Pregnancy Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.